Drugs / AG2304T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06717360 | Sep 2024 → Jul 2025 | hyperlipoproteinemia | Ahn-Gook Pharmaceuticals Co.,Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AG2304T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06717360 ↗ |
| Route | Oral | “AG2304T, QD, PO” NCT06717360 ↗ |